Kabat Rehabilitation Versus Mime Therapy on Facial Disability and Synkinesis in Patients of Bell's Palsy
Effects Of Kabat Rehabilitation Versus Mime Therapy On Facial Disability And Synkinesis In Patients Of Bell's Palsy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Ayesha Jamil, M.Phil
- Phone Number: +923244481031
- Email: ayeshabutt031@gmail.com
Study Contact Backup
- Name: Ayesha Amjad, MS
- Phone Number: +923054645864
- Email: ayeshaamjad056@gmail.com
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 5400
- The University of Lahore
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age group 25-50 years.
- Both male and female.
- Unilateral bell's paralysis.
- Not congenital in origin.
- Sub-acute and chronic cases.
Exclusion Criteria:
- Other neurological deficits include epilepsy and Alzheimer's disease.
- Traumatic onset.
- Surgical reconstruction (nerve or muscle reconstruction).
- Mental and psychological disorders i.e., schizophrenia, bipolar disorders.
- Skin diseases (eczema, urticarial) as electrical stimulation may affect the results.
- Any contraindications for massage like sunburn, bruising, or cuts.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Kabat Therapy
Kabat exercises primarily assist functional response in defective muscles through the general structure of muscles experiencing resistance.
After 6th week, resting and voluntary symmetries were recorded.
|
The participants of group A will receive Kabat Rehabilitation with routine physical therapy.
The protocol will be given to the participants for three sessions/week for six weeks.
Each session will be of 30 minutes.
|
|
Experimental: Mime Therapy
Mime therapy utilizes emotional input to access better movement patterns.
It is beneficial as it improves circulation and maintains muscle properties.
|
The participants of group B will receive Mime Therapy in addition to routine physical therapy.
The protocol will be given to the participants once a week for six weeks, while physical therapy will be given on alternate days.
Each session will be of 30 minutes.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Synkinesis
Time Frame: It will be assessed at baseline, at the third week and at six week.
|
Synkinesis will be accessed through the "House-Brackmann Scale".
It is classified as a universal scale.
This scale analyses the symmetry, synkinesis, stiffness, and global mobility of the face.
It is divided into six categories (normal, mild dysfunction, moderate dysfunction, moderately severe dysfunction, severe dysfunction, and total paralysis) and is a 0-6-point scale with 6 representing total paralysis.
|
It will be assessed at baseline, at the third week and at six week.
|
|
Level of Facial Disability
Time Frame: Change in functional status will be measured at the baseline, at 3rd week and at 6th week.
|
The level of Facial disability will be measured through the "Facial Disability Index Scale".
This scale has ten items that evaluate the patient's physical and social aspects (mastication, deglutition, communication, labial mobility, emotional alterations, and social integration).
It uses a hundred-point scale with a higher score indicating less impairment.
24 Minimum score for physical functioning: 0, Maximum score for physical functioning: 25, Minimum score for social and well-being: 5, Maximum score for social and well-being.
|
Change in functional status will be measured at the baseline, at 3rd week and at 6th week.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Ashfaq Dr Ahmed, PhD, The University of Lahore
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- REC-UOL-406-05-2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.